News & Press: Latest News

MDMA Statement on FDA’s Final Unique Device Identification Rule

Friday, September 20, 2013  
Share |
WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the FDA's final rule for the unique device identification (UDI) system:

"While we continue to review this final rule, it appears that FDA addressed a number of issues raised by stakeholders.  At the end of the day, both innovators and patients are best served by a cost effective and efficient UDI system.  MDMA will continue to work closely with FDA to ensure that UDI enhances patient safety and is not used by other parties in the health care system to stifle patient access or physician choice."